Correlation Between Dupont De and Rafarma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dupont De and Rafarma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Rafarma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Rafarma Pharmaceuticals, you can compare the effects of market volatilities on Dupont De and Rafarma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Rafarma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Rafarma Pharmaceuticals.
Diversification Opportunities for Dupont De and Rafarma Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dupont and Rafarma is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Rafarma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rafarma Pharmaceuticals and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Rafarma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rafarma Pharmaceuticals has no effect on the direction of Dupont De i.e., Dupont De and Rafarma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dupont De and Rafarma Pharmaceuticals
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.18 times more return on investment than Rafarma Pharmaceuticals. However, Dupont De Nemours is 5.57 times less risky than Rafarma Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Rafarma Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 8,327 in Dupont De Nemours on August 31, 2024 and sell it today you would earn a total of 63.00 from holding Dupont De Nemours or generate 0.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Rafarma Pharmaceuticals
Performance |
| Timeline |
| Dupont De Nemours |
| Rafarma Pharmaceuticals |
Dupont De and Rafarma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Rafarma Pharmaceuticals
The main advantage of trading using opposite Dupont De and Rafarma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Rafarma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rafarma Pharmaceuticals will offset losses from the drop in Rafarma Pharmaceuticals' long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Linde plc Ordinary | Dupont De vs. Ecolab Inc | Dupont De vs. Sherwin Williams Co |
| Rafarma Pharmaceuticals vs. Perk International | Rafarma Pharmaceuticals vs. SANUWAVE Health | Rafarma Pharmaceuticals vs. Verde Bio Holdings | Rafarma Pharmaceuticals vs. Bryn Resources |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |